Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Free Report) EVP Mark Brosius sold 77 shares of the firm’s stock in a transaction that occurred on Wednesday, August 19th. The stock was sold at an average price of $394.26, for a total value of $30,358.02. Following the transaction, the executive vice president owned 1,035 shares of the company’s stock, valued at $408,059.10. This trade represents a 6.92% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Mark Brosius also recently made the following trade(s):
- On Monday, August 17th, Mark Brosius sold 77 shares of Intuitive Surgical stock. The shares were sold at an average price of $390.67, for a total value of $30,081.59.
- On Friday, July 31st, Mark Brosius sold 28 shares of Intuitive Surgical stock. The stock was sold at an average price of $351.00, for a total value of $9,828.00.
- On Wednesday, July 29th, Mark Brosius sold 28 shares of Intuitive Surgical stock. The shares were sold at an average price of $360.21, for a total value of $10,085.88.
- On Monday, July 27th, Mark Brosius sold 28 shares of Intuitive Surgical stock. The shares were sold at an average price of $344.00, for a total transaction of $9,632.00.
- On Friday, June 12th, Mark Brosius sold 25 shares of Intuitive Surgical stock. The shares were sold at an average price of $414.13, for a total transaction of $10,353.25.
- On Wednesday, June 10th, Mark Brosius sold 23 shares of Intuitive Surgical stock. The stock was sold at an average price of $424.14, for a total transaction of $9,755.22.
- On Monday, June 8th, Mark Brosius sold 23 shares of Intuitive Surgical stock. The stock was sold at an average price of $420.12, for a total transaction of $9,662.76.
- On Friday, May 22nd, Mark Brosius sold 18 shares of Intuitive Surgical stock. The shares were sold at an average price of $439.80, for a total transaction of $7,916.40.
Intuitive Surgical Stock Down 5.8%
NASDAQ:ISRG opened at $374.48 on Friday. The firm has a market cap of $132.30 billion, a PE ratio of 42.90, a price-to-earnings-growth ratio of 2.88 and a beta of 1.46. Intuitive Surgical, Inc. has a 12 month low of $328.57 and a 12 month high of $603.88. The company’s 50-day moving average price is $389.12 and its two-hundred day moving average price is $437.10.
Institutional Inflows and Outflows
Hedge funds have recently bought and sold shares of the company. Prosperity Consulting Group LLC lifted its stake in Intuitive Surgical by 0.5% in the 3rd quarter. Prosperity Consulting Group LLC now owns 4,033 shares of the medical equipment provider’s stock valued at $1,804,000 after purchasing an additional 19 shares during the last quarter. WoodTrust Financial Corp grew its stake in shares of Intuitive Surgical by 0.5% during the fourth quarter. WoodTrust Financial Corp now owns 4,180 shares of the medical equipment provider’s stock worth $2,367,000 after buying an additional 20 shares during the last quarter. North Star Investment Management Corp. grew its stake in shares of Intuitive Surgical by 8.5% during the fourth quarter. North Star Investment Management Corp. now owns 269 shares of the medical equipment provider’s stock worth $152,000 after buying an additional 21 shares during the last quarter. Cornerstone Planning Group LLC increased its holdings in shares of Intuitive Surgical by 11.5% during the fourth quarter. Cornerstone Planning Group LLC now owns 203 shares of the medical equipment provider’s stock worth $106,000 after buying an additional 21 shares in the last quarter. Finally, Valeo Financial Advisors LLC lifted its stake in shares of Intuitive Surgical by 0.4% in the 4th quarter. Valeo Financial Advisors LLC now owns 4,941 shares of the medical equipment provider’s stock valued at $2,798,000 after acquiring an additional 21 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
Several equities analysts have issued reports on ISRG shares. Weiss Ratings reiterated a “hold (c)” rating on shares of Intuitive Surgical in a research report on Friday, August 14th. BNP Paribas Exane upgraded Intuitive Surgical to an “outperform” rating in a report on Tuesday, July 28th. UBS Group initiated coverage on Intuitive Surgical in a report on Tuesday, July 28th. They set a “neutral” rating and a $500.00 target price on the stock. Wells Fargo & Company restated an “overweight” rating and issued a $487.00 target price (down from $654.00) on shares of Intuitive Surgical in a research note on Friday, July 17th. Finally, Sanford C. Bernstein reaffirmed an “outperform” rating on shares of Intuitive Surgical in a report on Wednesday, August 12th. Twenty-two equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus price target of $508.68.
Get Our Latest Analysis on Intuitive Surgical
Intuitive Surgical News Roundup
Here are the key news stories impacting Intuitive Surgical this week:
- Positive Sentiment: Intuitive Surgical’s robotic-assisted surgery platform continues to attract investor interest, supported by the long-term shift toward minimally invasive procedures and recurring revenue from instruments, accessories and services. Intuitive Surgical robotic surgery platform article
- Positive Sentiment: The company is expanding its manufacturing footprint in Asia-Pacific with a new Penang facility. The plant should increase production capacity and position ISRG to serve rising regional demand for robotic surgery systems. Intuitive Surgical expands manufacturing in Asia-Pacific
- Positive Sentiment: Recent quarterly results showed revenue of $2.89 billion, up 18.4% year over year, while adjusted EPS of $2.80 exceeded the $2.48 consensus estimate. Procedures increased about 16%, and 468 da Vinci systems were placed, demonstrating continued demand. Analysts retain a broadly favorable view, with a consensus “Moderate Buy” rating and target prices materially above recent trading levels.
- Neutral Sentiment: Institutional activity was mixed in the latest quarter: 1,070 investors added ISRG shares while 1,306 reduced positions. Large additions by Invesco, JPMorgan and Arrowstreet were offset by notable reductions from T. Rowe Price, FMR and Winslow Capital, suggesting divided sentiment rather than a clear institutional trend.
- Negative Sentiment: Investors remain concerned that Intuitive Surgical maintained its 2026 da Vinci procedure-growth forecast at approximately 13.5%–15.5%, with results expected near the midpoint, despite the strong quarter. Management also expects tariffs to reduce 2026 non-GAAP gross margin by about 1% of revenue, with additional risk if tariffs rise. These factors have contributed to post-earnings valuation pressure. Intuitive Surgical cautious outlook article
- Negative Sentiment: Insider-trading data shows repeated open-market sales and no purchases over the past six months. EVP Mark Brosius’s recent sales totaled roughly $30,000 each and were made under a pre-arranged Rule 10b5-1 plan, limiting their significance individually, but the broader pattern may reinforce investor caution. Intuitive Surgical insider selling article
About Intuitive Surgical
Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.
In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.
Featured Articles
- Five stocks we like better than Intuitive Surgical
- 3 Energy Stocks Raising Dividends as the Sector Surges
- 5 Reasons the S&P 500 Could Keep Rallying Through Year-End
- Walmart’s Post-Earnings Drop Could Be a Buying Opportunity
- The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
